Mainstream

Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances

Illumina raises 2025 revenue and EPS guidance as clinical demand strengthens and multiomics acquisition advances

Post ContentilmnRead More

You might also be interested in reading Altcoin Transaction King? TRON Hits 42% Share As USDT, DeFi Explode.

August 1, 2025
In Mainstream